Tetsuo Nakayama Selected Research

Aseptic Meningitis

1/2019	Immunogenicity and safety of the new MMR vaccine containing measles AIK-C, rubella Takahashi, and mumps RIT4385 strains in Japanese children: a randomized phase I/II clinical trial.
1/2019	Causal relationship between immunological responses and adverse reactions following vaccination.
11/2015	Effect of age on the incidence of aseptic meningitis following immunization with monovalent mumps vaccine.
10/2009	Amino acid substitution at position 464 in the haemagglutinin-neuraminidase protein of a mumps virus Urabe strain enhanced the virus growth in neuroblastoma SH-SY5Y cells.
3/2007	A comparative study of the incidence of aseptic meningitis in symptomatic natural mumps patients and monovalent mumps vaccine recipients in Japan.
1/2007	Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tetsuo Nakayama Research Topics

Disease

29	Measles 02/2021 - 01/2002
16	Infections 07/2023 - 07/2003
14	Mumps 01/2019 - 04/2005
10	Human Influenza (Influenza) 03/2020 - 09/2004
10	Rubella (German Measles) 01/2019 - 01/2002
8	Whooping Cough (Pertussis) 11/2022 - 01/2014
6	Aseptic Meningitis 01/2019 - 01/2007
5	Asymptomatic Infections 11/2023 - 03/2007
5	Tetanus 11/2022 - 01/2014
5	Diphtheria 11/2022 - 01/2014
5	Respiratory Syncytial Virus Infections 10/2022 - 07/2003
4	Anaphylaxis (Anaphylactic Shock) 01/2023 - 01/2007
4	Neoplasms (Cancer) 04/2020 - 11/2002
3	Fever (Fevers) 01/2015 - 04/2006
3	Virus Diseases (Viral Diseases) 01/2015 - 12/2008
3	Communicable Diseases (Infectious Diseases) 12/2009 - 03/2003
2	COVID-19 07/2023 - 01/2023
2	Herpes Zoster 08/2022 - 10/2013
2	Chickenpox 01/2021 - 01/2015
2	Inflammation (Inflammations) 01/2016 - 02/2011
2	Hepatitis B 10/2013 - 01/2011
2	Brain Diseases (Brain Disorder) 12/2011 - 01/2007
2	Encephalitis (Encephalitis, Rasmussen) 11/2011 - 01/2007
2	Subacute Sclerosing Panencephalitis (SSPE) 11/2011 - 08/2003
2	Reinfection 03/2008 - 07/2003
2	Hypersensitivity (Allergy) 01/2007 - 01/2004
1	Severe Acute Respiratory Syndrome 03/2024
1	Breakthrough Infections 07/2023
1	Bronchiolitis 10/2022
1	Pneumonia (Pneumonitis) 10/2022
1	Leukocytosis (Pleocytosis) 01/2022
1	Dysgerminoma 04/2020
1	Poliomyelitis (Polio) 01/2019
1	Chronic Pain 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Meningeal Carcinomatosis 01/2018
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2016
1	Injection Site Reaction 11/2015
1	Cicatrix (Scar) 06/2014
1	Contracture 06/2014

Drug/Important Bio-Agent (IBA)

47	VaccinesIBA 01/2023 - 01/2002
14	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2004
14	AntibodiesIBA 11/2022 - 08/2003
9	AntigensIBA 07/2023 - 09/2004
7	CytokinesIBA 11/2023 - 12/2011
6	Measles VaccineIBA 01/2019 - 12/2006
6	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2019 - 04/2006
5	Immunoglobulin G (IgG)IBA 07/2023 - 03/2008
5	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2003
5	Combined VaccinesIBA 01/2019 - 01/2002
4	ToxoidsIBA 01/2019 - 01/2014
4	Complementary DNA (cDNA)IBA 01/2016 - 01/2004
3	Pertussis VaccineIBA 11/2022 - 01/2014
3	Hemagglutinins (Hemagglutinin)IBA 02/2021 - 01/2004
3	Respiratory Syncytial Virus VaccinesIBA 02/2021 - 02/2011
3	EnzymesIBA 01/2019 - 07/2003
3	Neutralizing AntibodiesIBA 01/2016 - 08/2003
2	Interleukin-6 (Interleukin 6)IBA 07/2023 - 01/2009
2	Messenger RNA (mRNA)IBA 01/2023 - 04/2016
2	Immunoglobulin E (IgE)IBA 01/2023 - 11/2015
2	InterleukinsIBA 10/2022 - 12/2011
2	Diphtheria-Tetanus-acellular Pertussis Vaccines (Tripedia)FDA Link 01/2019 - 11/2018
2	Rubella VaccineIBA 05/2016 - 01/2002
2	Palivizumab FDA Link 05/2016 - 04/2016
2	Viral AntigensIBA 01/2016 - 07/2003
2	Mumps Vaccine (Vaccine, Mumps)IBA 11/2015 - 03/2007
2	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 04/2014
2	Attenuated VaccinesIBA 01/2015 - 01/2002
2	GelatinIBA 01/2007 - 01/2004
1	Interleukin-5 (Interleukin 5)IBA 07/2023
1	Lipid NanoparticlesIBA 01/2023
1	SolutionsIBA 11/2022
1	Immunoglobulin A (IgA)IBA 11/2022
1	ChemokinesIBA 10/2022
1	AS01B adjuvantIBA 08/2022
1	Herpes Zoster VaccineIBA 08/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	GTP-Binding Proteins (G-Protein)IBA 02/2021
1	placental alkaline phosphataseIBA 04/2020
1	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 01/2019
1	Inactivated VaccinesIBA 01/2019
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2019
1	GadoliniumIBA 01/2018
1	SugarsIBA 10/2016
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2016
1	Chemokine CCL5IBA 04/2016
1	Interleukin-10 (Interleukin 10)IBA 04/2016
1	Interleukin-13IBA 04/2016
1	Interleukin-4 (Interleukin 4)IBA 04/2016
1	Hepatitis B e AntigensIBA 01/2016
1	phenoxyethanol (2-phenoxyethanol)IBA 11/2015
1	Pertussis ToxinIBA 09/2015
1	5' Untranslated Regions (5' UTR)IBA 09/2015

Therapy/Procedure

2	Renal Dialysis (Hemodialysis) 03/2024 - 07/2023
1	Ovariectomy (Oophorectomy) 04/2020
1	Drug Therapy (Chemotherapy) 01/2018
1	Radiotherapy 01/2018
1	Liver Transplantation 01/2015
1	Intramuscular Injections 06/2014